COVID-19 ARNm vaccine-induced immune thrombotic thrombocytopenia: case report

https://doi.org/10.36109/rmg.v162i1.661
mRNA vaccine-induced immune thrombocytopenia COVID-19

Authors

  • Jorge Guardado-Irias
    jrg0016@gmail.com
    Departamento de Medicina Interna. Hospital Roosevelt, Guatemala, Guatemala., Guatemala
  • Héctor Zavala Departamento de Medicina Interna. Hospital Roosevelt, Guatemala, Guatemala., Guatemala
  • Nancy Sandoval Unidad de Infectología, Hospital Roosevelt, Guatemala, Guatemala. , Guatemala
  • Silvana Torselli Unidad de Hematología. Hospital Roosevelt, Guatemala, Guatemala., Guatemala
Vol. 162 No. 1: January - February, 2023
Case Report
November 7, 2022
February 23, 2023

The clinical case of a 22-year-old female patient with mRNA vaccine-induced immune thrombocytopenia (VITT) against COVID-19 is presented. This syndrome is associated with a pathophysiology similar to heparin-induced thrombocytopenia (HIT),

How to Cite

COVID-19 ARNm vaccine-induced immune thrombotic thrombocytopenia: case report. (2023). Revista médica (Colegio De Médicos Y Cirujanos De Guatemala), 162(1), 35-38. https://doi.org/10.36109/rmg.v162i1.661